Literature DB >> 17190628

Systematic review of rosacea treatments.

Esther J van Zuuren1, Aditya K Gupta, Melissa D Gover, Mark Graber, Sally Hollis.   

Abstract

BACKGROUND: Rosacea is a common chronic skin and ocular condition. It is unclear which treatments are most effective. We have conducted a Cochrane review of rosacea therapies. This article is a distillation of that work.
OBJECTIVE: We sought to assess the evidence for the efficacy and safety of rosacea therapies.
METHODS: Multiple databases were systematically searched. Randomized controlled trials in people with moderate to severe rosacea were included. Study selection, assessment of methodologic quality, data extraction, and analysis were carried out by two independent researchers.
RESULTS: In all, 29 studies met inclusion criteria. Topical metronidazole is more effective than placebo (odds ratio 5.96, 95% confidence interval 2.95-12.06). Azelaic acid is more effective than placebo (odds ratio 2.45, 95% confidence interval 1.82-3.28). Firm conclusions could not be drawn about other therapies. LIMITATIONS: The quality of the studies was generally poor.
CONCLUSIONS: There is evidence that topical metronidazole and azelaic acid are effective. There is some evidence that oral metronidazole and tetracycline are effective. More well-designed, randomized controlled trials are required to provide better evidence of the efficacy and safety of other rosacea therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190628     DOI: 10.1016/j.jaad.2006.04.084

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Oxymetazoline (topical): rosacea.

Authors:  Joyce A Generali; Dennis J Cada
Journal:  Hosp Pharm       Date:  2013-07

Review 2.  Assessing the compliance of systematic review articles published in leading dermatology journals with the PRISMA statement guidelines: A systematic review.

Authors:  Buket Gundogan; Naeem Dowlut; Shivanchan Rajmohan; Mimi R Borrelli; Mirabel Millip; Christos Iosifidis; Yagazie Z Udeaja; Ginimol Mathew; Alexander Fowler; Riaz Agha
Journal:  JAAD Int       Date:  2020-09-07

Review 3.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

4.  A usability study of two formats of a shortened systematic review for clinicians.

Authors:  Laure Perrier; M Ryan Kealey; Sharon E Straus
Journal:  BMJ Open       Date:  2014-12-23       Impact factor: 2.692

5.  The efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and age.

Authors:  Hee Sun Lim; Seung-Chul Lee; Young Ho Won; Jee-Bum Lee
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

6.  Severe Rosacea: A Case Report.

Authors:  Ebrahim Shirzadeh; Abbas Bagheri; Mojtaba Fattahi Abdizadeh; Mozhgan Rezaei Kanavi
Journal:  J Ophthalmic Vis Res       Date:  2017 Oct-Dec

7.  Dermatology for the allergist.

Authors:  Dennis Kim; Richard Lockey
Journal:  World Allergy Organ J       Date:  2010-06-15       Impact factor: 4.084

8.  Development of two shortened systematic review formats for clinicians.

Authors:  Laure Perrier; Nav Persaud; Anita Ko; Monika Kastner; Jeremy Grimshaw; K Ann McKibbon; Sharon E Straus
Journal:  Implement Sci       Date:  2013-06-14       Impact factor: 7.327

9.  Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease.

Authors:  Markus Reinholz; Thomas Ruzicka; Jürgen Schauber
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.